nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—DDC—nerve—acquired immunodeficiency syndrome	0.0421	0.36	CbGeAlD
Carbidopa—DDC—blood plasma—acquired immunodeficiency syndrome	0.0318	0.272	CbGeAlD
Carbidopa—DDC—lung—acquired immunodeficiency syndrome	0.0102	0.0874	CbGeAlD
Carbidopa—DDC—nervous system—acquired immunodeficiency syndrome	0.00946	0.081	CbGeAlD
Carbidopa—DDC—central nervous system—acquired immunodeficiency syndrome	0.00911	0.0779	CbGeAlD
Carbidopa—DDC—brain—acquired immunodeficiency syndrome	0.00723	0.0619	CbGeAlD
Carbidopa—DDC—lymph node—acquired immunodeficiency syndrome	0.00699	0.0598	CbGeAlD
Carbidopa—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000774	0.000876	CcSEcCtD
Carbidopa—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000774	0.000876	CcSEcCtD
Carbidopa—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000772	0.000875	CcSEcCtD
Carbidopa—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000772	0.000874	CcSEcCtD
Carbidopa—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000771	0.000873	CcSEcCtD
Carbidopa—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000771	0.000873	CcSEcCtD
Carbidopa—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000769	0.000871	CcSEcCtD
Carbidopa—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000768	0.00087	CcSEcCtD
Carbidopa—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000767	0.000869	CcSEcCtD
Carbidopa—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000767	0.000868	CcSEcCtD
Carbidopa—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000765	0.000867	CcSEcCtD
Carbidopa—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000764	0.000866	CcSEcCtD
Carbidopa—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000763	0.000864	CcSEcCtD
Carbidopa—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000762	0.000863	CcSEcCtD
Carbidopa—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000762	0.000863	CcSEcCtD
Carbidopa—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000761	0.000862	CcSEcCtD
Carbidopa—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00076	0.000861	CcSEcCtD
Carbidopa—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000758	0.000858	CcSEcCtD
Carbidopa—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000758	0.000858	CcSEcCtD
Carbidopa—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000758	0.000858	CcSEcCtD
Carbidopa—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000755	0.000856	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000753	0.000852	CcSEcCtD
Carbidopa—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000752	0.000851	CcSEcCtD
Carbidopa—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000752	0.000851	CcSEcCtD
Carbidopa—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000751	0.000851	CcSEcCtD
Carbidopa—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000751	0.000851	CcSEcCtD
Carbidopa—Cough—Saquinavir—acquired immunodeficiency syndrome	0.00075	0.000849	CcSEcCtD
Carbidopa—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000749	0.000849	CcSEcCtD
Carbidopa—Pain—Indinavir—acquired immunodeficiency syndrome	0.000745	0.000844	CcSEcCtD
Carbidopa—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000745	0.000844	CcSEcCtD
Carbidopa—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000745	0.000844	CcSEcCtD
Carbidopa—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000745	0.000843	CcSEcCtD
Carbidopa—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000745	0.000843	CcSEcCtD
Carbidopa—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000744	0.000842	CcSEcCtD
Carbidopa—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000742	0.00084	CcSEcCtD
Carbidopa—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000741	0.000839	CcSEcCtD
Carbidopa—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000741	0.000839	CcSEcCtD
Carbidopa—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00074	0.000838	CcSEcCtD
Carbidopa—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00074	0.000838	CcSEcCtD
Carbidopa—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000739	0.000837	CcSEcCtD
Carbidopa—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000738	0.000836	CcSEcCtD
Carbidopa—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000738	0.000836	CcSEcCtD
Carbidopa—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000736	0.000834	CcSEcCtD
Carbidopa—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000735	0.000833	CcSEcCtD
Carbidopa—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000735	0.000832	CcSEcCtD
Carbidopa—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000734	0.000832	CcSEcCtD
Carbidopa—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000734	0.000831	CcSEcCtD
Carbidopa—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000732	0.000829	CcSEcCtD
Carbidopa—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000732	0.000829	CcSEcCtD
Carbidopa—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000729	0.000826	CcSEcCtD
Carbidopa—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000729	0.000825	CcSEcCtD
Carbidopa—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000727	0.000823	CcSEcCtD
Carbidopa—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000725	0.000821	CcSEcCtD
Carbidopa—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000723	0.000819	CcSEcCtD
Carbidopa—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000721	0.000816	CcSEcCtD
Carbidopa—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000718	0.000814	CcSEcCtD
Carbidopa—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000717	0.000812	CcSEcCtD
Carbidopa—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000716	0.000811	CcSEcCtD
Carbidopa—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000716	0.000811	CcSEcCtD
Carbidopa—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000715	0.00081	CcSEcCtD
Carbidopa—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000715	0.00081	CcSEcCtD
Carbidopa—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000714	0.000808	CcSEcCtD
Carbidopa—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000713	0.000808	CcSEcCtD
Carbidopa—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000713	0.000807	CcSEcCtD
Carbidopa—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000713	0.000807	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000711	0.000805	CcSEcCtD
Carbidopa—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00071	0.000805	CcSEcCtD
Carbidopa—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00071	0.000804	CcSEcCtD
Carbidopa—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00071	0.000804	CcSEcCtD
Carbidopa—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000708	0.000802	CcSEcCtD
Carbidopa—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000707	0.000801	CcSEcCtD
Carbidopa—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000705	0.000798	CcSEcCtD
Carbidopa—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000704	0.000798	CcSEcCtD
Carbidopa—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000704	0.000798	CcSEcCtD
Carbidopa—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000704	0.000798	CcSEcCtD
Carbidopa—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000704	0.000797	CcSEcCtD
Carbidopa—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000703	0.000796	CcSEcCtD
Carbidopa—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000703	0.000796	CcSEcCtD
Carbidopa—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000701	0.000794	CcSEcCtD
Carbidopa—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000701	0.000794	CcSEcCtD
Carbidopa—Headache—Nevirapine—acquired immunodeficiency syndrome	0.0007	0.000793	CcSEcCtD
Carbidopa—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000698	0.000791	CcSEcCtD
Carbidopa—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000697	0.000789	CcSEcCtD
Carbidopa—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000696	0.000788	CcSEcCtD
Carbidopa—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000695	0.000787	CcSEcCtD
Carbidopa—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000694	0.000786	CcSEcCtD
Carbidopa—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000693	0.000784	CcSEcCtD
Carbidopa—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00069	0.000782	CcSEcCtD
Carbidopa—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00069	0.000781	CcSEcCtD
Carbidopa—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000689	0.000781	CcSEcCtD
Carbidopa—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000689	0.000781	CcSEcCtD
Carbidopa—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000688	0.000779	CcSEcCtD
Carbidopa—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000687	0.000778	CcSEcCtD
Carbidopa—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000686	0.000777	CcSEcCtD
Carbidopa—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000685	0.000776	CcSEcCtD
Carbidopa—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000683	0.000773	CcSEcCtD
Carbidopa—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000682	0.000773	CcSEcCtD
Carbidopa—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000681	0.000772	CcSEcCtD
Carbidopa—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000681	0.000771	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00068	0.000771	CcSEcCtD
Carbidopa—Rash—Stavudine—acquired immunodeficiency syndrome	0.00068	0.00077	CcSEcCtD
Carbidopa—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000679	0.00077	CcSEcCtD
Carbidopa—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000679	0.00077	CcSEcCtD
Carbidopa—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000679	0.000769	CcSEcCtD
Carbidopa—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000678	0.000768	CcSEcCtD
Carbidopa—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000678	0.000768	CcSEcCtD
Carbidopa—Headache—Stavudine—acquired immunodeficiency syndrome	0.000676	0.000765	CcSEcCtD
Carbidopa—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000676	0.000765	CcSEcCtD
Carbidopa—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000675	0.000764	CcSEcCtD
Carbidopa—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000674	0.000763	CcSEcCtD
Carbidopa—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000674	0.000763	CcSEcCtD
Carbidopa—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000674	0.000763	CcSEcCtD
Carbidopa—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000673	0.000762	CcSEcCtD
Carbidopa—Rash—Abacavir—acquired immunodeficiency syndrome	0.00067	0.000759	CcSEcCtD
Carbidopa—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000669	0.000758	CcSEcCtD
Carbidopa—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000669	0.000758	CcSEcCtD
Carbidopa—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000669	0.000757	CcSEcCtD
Carbidopa—Headache—Abacavir—acquired immunodeficiency syndrome	0.000666	0.000754	CcSEcCtD
Carbidopa—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000665	0.000753	CcSEcCtD
Carbidopa—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000663	0.000751	CcSEcCtD
Carbidopa—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000663	0.000751	CcSEcCtD
Carbidopa—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000659	0.000747	CcSEcCtD
Carbidopa—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000658	0.000746	CcSEcCtD
Carbidopa—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000655	0.000742	CcSEcCtD
Carbidopa—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000655	0.000742	CcSEcCtD
Carbidopa—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000654	0.000741	CcSEcCtD
Carbidopa—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000654	0.000741	CcSEcCtD
Carbidopa—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000651	0.000737	CcSEcCtD
Carbidopa—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000651	0.000737	CcSEcCtD
Carbidopa—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00065	0.000736	CcSEcCtD
Carbidopa—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000649	0.000736	CcSEcCtD
Carbidopa—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000648	0.000734	CcSEcCtD
Carbidopa—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000647	0.000733	CcSEcCtD
Carbidopa—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000644	0.00073	CcSEcCtD
Carbidopa—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000643	0.000728	CcSEcCtD
Carbidopa—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000642	0.000727	CcSEcCtD
Carbidopa—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000642	0.000727	CcSEcCtD
Carbidopa—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000641	0.000726	CcSEcCtD
Carbidopa—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000641	0.000726	CcSEcCtD
Carbidopa—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000638	0.000722	CcSEcCtD
Carbidopa—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000634	0.000719	CcSEcCtD
Carbidopa—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000634	0.000718	CcSEcCtD
Carbidopa—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000631	0.000715	CcSEcCtD
Carbidopa—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00063	0.000713	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000629	0.000713	CcSEcCtD
Carbidopa—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000628	0.000712	CcSEcCtD
Carbidopa—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000626	0.000709	CcSEcCtD
Carbidopa—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000625	0.000708	CcSEcCtD
Carbidopa—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000625	0.000708	CcSEcCtD
Carbidopa—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000625	0.000708	CcSEcCtD
Carbidopa—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000624	0.000706	CcSEcCtD
Carbidopa—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000623	0.000706	CcSEcCtD
Carbidopa—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000623	0.000706	CcSEcCtD
Carbidopa—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000623	0.000706	CcSEcCtD
Carbidopa—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000623	0.000706	CcSEcCtD
Carbidopa—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00062	0.000702	CcSEcCtD
Carbidopa—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000617	0.000699	CcSEcCtD
Carbidopa—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000617	0.000699	CcSEcCtD
Carbidopa—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.00061	0.000691	CcSEcCtD
Carbidopa—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000607	0.000687	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000606	0.000686	CcSEcCtD
Carbidopa—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000605	0.000686	CcSEcCtD
Carbidopa—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000605	0.000685	CcSEcCtD
Carbidopa—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000601	0.000681	CcSEcCtD
Carbidopa—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000601	0.00068	CcSEcCtD
Carbidopa—Pain—Saquinavir—acquired immunodeficiency syndrome	0.0006	0.000679	CcSEcCtD
Carbidopa—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.0006	0.000679	CcSEcCtD
Carbidopa—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000597	0.000676	CcSEcCtD
Carbidopa—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000596	0.000676	CcSEcCtD
Carbidopa—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000596	0.000675	CcSEcCtD
Carbidopa—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000596	0.000675	CcSEcCtD
Carbidopa—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000595	0.000674	CcSEcCtD
Carbidopa—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000591	0.000669	CcSEcCtD
Carbidopa—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000591	0.000669	CcSEcCtD
Carbidopa—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00059	0.000669	CcSEcCtD
Carbidopa—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000589	0.000667	CcSEcCtD
Carbidopa—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000587	0.000665	CcSEcCtD
Carbidopa—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000583	0.00066	CcSEcCtD
Carbidopa—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000582	0.000659	CcSEcCtD
Carbidopa—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000581	0.000658	CcSEcCtD
Carbidopa—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000579	0.000656	CcSEcCtD
Carbidopa—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000578	0.000655	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000578	0.000654	CcSEcCtD
Carbidopa—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000577	0.000653	CcSEcCtD
Carbidopa—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000576	0.000653	CcSEcCtD
Carbidopa—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000576	0.000653	CcSEcCtD
Carbidopa—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000576	0.000653	CcSEcCtD
Carbidopa—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000574	0.00065	CcSEcCtD
Carbidopa—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000572	0.000648	CcSEcCtD
Carbidopa—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000572	0.000648	CcSEcCtD
Carbidopa—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000565	0.00064	CcSEcCtD
Carbidopa—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000564	0.000638	CcSEcCtD
Carbidopa—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000558	0.000632	CcSEcCtD
Carbidopa—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000557	0.000631	CcSEcCtD
Carbidopa—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000557	0.000631	CcSEcCtD
Carbidopa—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000555	0.000628	CcSEcCtD
Carbidopa—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000555	0.000628	CcSEcCtD
Carbidopa—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000554	0.000628	CcSEcCtD
Carbidopa—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000551	0.000625	CcSEcCtD
Carbidopa—Rash—Indinavir—acquired immunodeficiency syndrome	0.00055	0.000623	CcSEcCtD
Carbidopa—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000549	0.000622	CcSEcCtD
Carbidopa—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000547	0.00062	CcSEcCtD
Carbidopa—Headache—Indinavir—acquired immunodeficiency syndrome	0.000546	0.000619	CcSEcCtD
Carbidopa—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000545	0.000617	CcSEcCtD
Carbidopa—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000539	0.000611	CcSEcCtD
Carbidopa—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000537	0.000608	CcSEcCtD
Carbidopa—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000532	0.000602	CcSEcCtD
Carbidopa—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000529	0.000599	CcSEcCtD
Carbidopa—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000529	0.000599	CcSEcCtD
Carbidopa—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000524	0.000593	CcSEcCtD
Carbidopa—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000523	0.000592	CcSEcCtD
Carbidopa—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000521	0.00059	CcSEcCtD
Carbidopa—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000519	0.000588	CcSEcCtD
Carbidopa—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000519	0.000588	CcSEcCtD
Carbidopa—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000518	0.000587	CcSEcCtD
Carbidopa—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000517	0.000585	CcSEcCtD
Carbidopa—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000516	0.000584	CcSEcCtD
Carbidopa—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000516	0.000584	CcSEcCtD
Carbidopa—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000503	0.00057	CcSEcCtD
Carbidopa—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000501	0.000568	CcSEcCtD
Carbidopa—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000499	0.000565	CcSEcCtD
Carbidopa—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000497	0.000563	CcSEcCtD
Carbidopa—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000496	0.000562	CcSEcCtD
Carbidopa—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000496	0.000562	CcSEcCtD
Carbidopa—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000494	0.000559	CcSEcCtD
Carbidopa—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000493	0.000558	CcSEcCtD
Carbidopa—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000489	0.000554	CcSEcCtD
Carbidopa—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000482	0.000546	CcSEcCtD
Carbidopa—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.00048	0.000544	CcSEcCtD
Carbidopa—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00048	0.000544	CcSEcCtD
Carbidopa—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000473	0.000536	CcSEcCtD
Carbidopa—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000468	0.00053	CcSEcCtD
Carbidopa—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000464	0.000525	CcSEcCtD
Carbidopa—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000463	0.000525	CcSEcCtD
Carbidopa—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00046	0.00052	CcSEcCtD
Carbidopa—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000459	0.00052	CcSEcCtD
Carbidopa—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000458	0.000519	CcSEcCtD
Carbidopa—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000457	0.000517	CcSEcCtD
Carbidopa—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000446	0.000505	CcSEcCtD
Carbidopa—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000443	0.000501	CcSEcCtD
Carbidopa—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000442	0.000501	CcSEcCtD
Carbidopa—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000442	0.0005	CcSEcCtD
Carbidopa—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000439	0.000498	CcSEcCtD
Carbidopa—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000433	0.00049	CcSEcCtD
Carbidopa—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000425	0.000482	CcSEcCtD
Carbidopa—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000422	0.000478	CcSEcCtD
Carbidopa—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000422	0.000477	CcSEcCtD
Carbidopa—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000419	0.000475	CcSEcCtD
Carbidopa—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000417	0.000472	CcSEcCtD
Carbidopa—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000397	0.00045	CcSEcCtD
Carbidopa—Epinephrine—TNF—acquired immunodeficiency syndrome	0.000223	1	CrCbGaD
